Swedish Orphan Biovitrum AB (publ) provided revenue guidance for the year 2024. For the period, the company anticipated revenue to grow by a high single-digit percentage at CER.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
282.4 SEK | +1.66% | +0.79% | +5.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.77% | 9.11B | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
-17.66% | 7.32B |
- Stock Market
- Equities
- SOBI Stock
- News Swedish Orphan Biovitrum AB
- Swedish Orphan Biovitrum AB Provides Revenue Guidance for the Year 2024